Henry Schein, Inc. (HSIC)
Stock Price Chart
Key Info
| Market Cap | 9.68B |
| Revenue (ttm) | 9.29B |
| Net Income (ttm) | 589.88M |
| Shares Out | 142.77M |
| EPS (ttm) | 4.06 |
| PE Ratio | 16.70 |
| Forward PE | 31.15 |
| Dividend | n/a |
| Dividend Yield | n/a |
Stock Quote
| Trading Day | Aug 7, 2020 |
| Last Price | $67.80 |
| Previous Close | $66.98 |
| Change ($) | 0.82 |
| Change (%) | 1.22% |
| Day's Open | 66.71 |
| Day's Range | 66.61 - 67.84 |
| Day's Volume | 1,332,870 |
| 52-Week Range | 41.85 - 73.99 |
More Stats
| Market Cap | 9.68B |
| Enterprise Value | 10.74B |
| Earnings Date (est) | Nov 10, 2020 |
| Ex-Dividend Date | n/a |
| Shares Outstanding | 142.77M |
| Float | 141.17M |
| EPS (basic) | 4.03 |
| EPS (diluted) | 4.06 |
| FCF / Share | 3.15 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Earnings Yield | 5.99% |
| FCF Yield | 4.63% |
| Payout Ratio | n/a |
| Shares Short | 14.22M |
| Short Ratio | 9.89 |
| Short % of Float | 12.54% |
| Beta | 0.99 |
| PE Ratio | 16.70 |
| Forward PE | 31.15 |
| P/FCF Ratio | 21.60 |
| PS Ratio | 1.04 |
| PB Ratio | 3.32 |
| Revenue | 9.29B |
| Operating Income | 549.96M |
| Net Income | 589.88M |
| Free Cash Flow | 448.23M |
| Net Cash | -1.06B |
| Net Cash / Share | -7.41 |
| Gross Margin | 33.27% |
| Operating Margin | 5.92% |
| Profit Margin | 6.30% |
| FCF Margin | 4.82% |
| ROA | 4.93% |
| ROE | 15.73% |
| ROIC | 23.70% |
Analyst Summary
Analyst Consensus: Overweight
Financial Performance
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 9,986 | 9,418 | 8,883 | 11,572 | 10,630 | 10,371 | 9,561 | 8,940 | 8,530 | 7,527 |
| Revenue Growth | 6.03% | 6.01% | -23.23% | 8.86% | 2.49% | 8.48% | 6.94% | 4.8% | 13.33% | - |
| Gross Profit | 3,091 | 2,911 | 2,747 | 3,226 | 3,007 | 2,911 | 2,656 | 2,508 | 2,418 | 2,171 |
| Operating Income | 718 | 601 | 670 | 772 | 734 | 715 | 677 | 619 | 582 | 521 |
| Net Income | 695 | 536 | 406 | 507 | 479 | 466 | 432 | 388 | 368 | 326 |
| Shares Outstanding | 148 | 153 | 157 | 162 | 166 | 169 | 172 | 175 | 180 | 180 |
| Earnings Per Share | 4.65 | 3.49 | 2.57 | 3.10 | 2.85 | 2.72 | 2.47 | 2.16 | 1.99 | 1.75 |
| EPS Growth | 33.24% | 35.8% | -17.1% | 8.77% | 4.78% | 10.34% | 14.12% | 8.82% | 13.75% | - |
| Dividend Per Share | 16.83 | - | - | - | - | - | - | - | - | - |
| Operating Cash Flow | 654 | 685 | 546 | 643 | 616 | 593 | 664 | 408 | 555 | 395 |
| Capital Expenditures | -76.22 | -71.28 | -62.40 | -70.18 | -71.68 | -82.12 | -60.22 | -51.24 | -45.18 | -39.00 |
| Free Cash Flow | 578 | 613 | 483 | 572 | 544 | 510 | 604 | 357 | 509 | 356 |
| Cash & Equivalents | 106 | 56.89 | 175 | 62.38 | 72.09 | 89.47 | 189 | 122 | 147 | 150 |
| Total Debt | 998 | 1,940 | 1,666 | 1,219 | 810 | 731 | 485 | 533 | 441 | 441 |
| Net Cash / Debt | -892 | -1,883 | -1,491 | -1,156 | -738 | -642 | -297 | -411 | -294 | -291 |
| Assets | 7,151 | 8,501 | 7,864 | 6,760 | 6,505 | 6,139 | 5,625 | 5,334 | 4,740 | 4,547 |
| Liabilities | 3,234 | 4,647 | 4,207 | 3,352 | 3,076 | 2,758 | 2,339 | 2,283 | 1,904 | 1,830 |
| Book Value | 2,998 | 2,961 | 2,811 | 2,793 | 2,884 | 2,814 | 2,785 | 2,614 | 2,432 | 2,412 |
Company Profile
Company Details
| Full Name | Henry Schein, Inc. |
| Country | United States |
| Employees | 19,000 |
| CEO | Stanley M. Bergman |
Stock Information
| Ticker Symbol | HSIC |
| Stock Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Distribution |
| Unique Identifier | NASDAQ: HSIC |
| IPO Date | November 3, 1995 |
Description
Henry Schein, Inc., a solutions company for health care professionals, provides health care products and services to office-based dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates in two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.